Human Fecal Bile Acid Analysis after Investigational Microbiota-Based Live Biotherapeutic Delivery for Recurrent <i>Clostridioides difficile</i> Infection

Microbiome-based therapeutics are increasingly evaluated as a strategy to reduce recurrent <i>Clostridioides difficile</i> infection (rCDI), with proposed mechanisms including restoration of the microbiota and microbiota-mediated functions, such as bile acid (BA) metabolism. This study r...

Full description

Bibliographic Details

Published in:	Microorganisms
Main Authors:	Romeo Papazyan, Nicky Ferdyan, Karthik Srinivasan, Carlos Gonzalez, William D. Shannon, Ken Blount, Bryan C. Fuchs
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Subjects:	<i>Clostridioides difficile</i> dysbiosis bile acids RBX2660 microbiota-based investigational therapeutic
Online Access:	https://www.mdpi.com/2076-2607/11/1/135